Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Skin and Subcutaneous Tissue Bacterial Infections Clinical Trial

Official title:
A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections

Status Completed

Clinical Trial Summary

This study was designed to evaluate the efficacy of delafloxacin patients with acute bacterial skin and soft tissue infections (ABSSSI).

Clinical Trial Description

The efficacy and safety of delafloxacin, compared to that of vancomycin plus aztreonam, will be evaluated in a population of patients with acute bacterial skin and soft tissue infections (ABSSSI), including major cutaneous abscesses, wound infections, cellulitis/erysipelas, and burn-related infections. ;

Study Design

Related Conditions & MeSH terms

Bacterial Infections
Communicable Diseases
Infection
Skin and Subcutaneous Tissue Bacterial Infections

Clinical Trial Details

NCT number	NCT01811732
Study type	Interventional
Source	Melinta Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	April 2013
Completion date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01421511` - TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections	Phase 3
Active, not recruiting	`NCT02572791` - Staph Household Intervention for Eradication (SHINE)	Phase 4
Completed	`NCT01984684` - Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections	Phase 3
Completed	`NCT02796716` - Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections	N/A
Completed	`NCT01283581` - A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections	Phase 2
Completed	`NCT01519492` - A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci	Phase 2
Completed	`NCT02060513` - Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections	N/A
Completed	`NCT01170221` - TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.	Phase 3
Completed	`NCT03964493` - TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection	Phase 2